| PUBCHEM ID |
118796433
|
| UNII |
432383E045
|
| Preferred Term |
N,N-BIS(2-(3-CYANO-6-HYDROXY-4-METHYL-2-PYRIDONE-1-YL)-ETHYL)BENZAMIDE
|
| CAS |
459856-86-1
|
| INCHIKEY |
ATBGFOIRNJKIRE-UHFFFAOYSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC(C(C#N)=C(N1CCN(CCN(C(C=C2C)=O)C(O)=C2C#N)C(c2ccccc2)=O)O)=CC1=O
|
| Total Surface Area |
361,35
|
| Relative PSA |
0,28529
|
| TPSA |
148,97
|
| cLogS |
-4,747
|
| MW |
473,488
|
| cLogP |
1,4445
|
| H-Acceptors |
10
|
| H-Donors |
2
|
| Ro5 violations |
0
|
| Druglikeness |
-3,4104
|
| DrugScore |
0,313896772206641
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,5981
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,6826
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,3554
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,3794
|
| Carcinogenicity (Three-class) |
Non-required
|
